StockTipsArenaBeta

BUY Divi's Laboratories Limited — Chandan Taparia, Motilal Oswal

BUYDivi's Laboratories Limited
Divi's Laboratories share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Intraday)12 Aug 2026, 10:18 am ISTvia NDTV Profit

Entry₹8,613Inferred
Target₹8,850
Total upside +2.75% (call closed)
Stop loss₹8,420-2.24% risk
At expiry₹8,486.512 Aug 2026, 3:05 pm
Expired-1.47%
Follow Chandan Taparia for new calls(13% target hit, 72 closed calls)Get alertsWatch DIVISLAB for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 12 Aug 2026
2 supporting2 neutral0 opposing
Supports the BUY call (2)

6 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·12 Aug · today

Divi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth

NewsGoogle News·6 Aug · 6d ago

(opens in new tab)
Neutral / worth noting (2)

Nifty 24,500 पर फिसला, Divi's, MCX और Eternal पर रखें नज़र!

NewsGoogle News·12 Aug · today

(opens in new tab)

Divi’s Laboratories Posts Q1 FY27 Earnings Call Transcript for Investors

NewsGoogle News·6 Aug · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Divi's Laboratories

All analyst calls on Divi's Laboratories

More from Chandan Taparia, Motilal Oswal

Every call and its outcome